[HTML][HTML] Venous thromboembolic disease in COVID-19, pathophysiology, therapy and prophylaxis

…, M Sobiecka, W Tomkowski, M Szturmowicz - International journal of …, 2022 - mdpi.com
For over two years, the world has been facing the epidemiological and health challenge of
the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory …

[HTML][HTML] Guidelines of the polish respiratory society on the diagnosis and treatment of progressive fibrosing interstitial lung diseases other than idiopathic pulmonary …

…, M Sobiecka, RA Soroka-Dąda, M Szołkowska… - … in Respiratory Medicine, 2022 - mdpi.com
… MS (Małgorzata Sobiecka) received lecture fees and travel grants and participated in
advisory boards for Roche and Boehringer Ingelheim. RAS-D. declared no conflicts of interest. …

Guidelines of the Polish Respiratory Society for diagnosis and treatment of idiopathic pulmonary fibrosis

…, M Sobiecka, M Szołkowska… - Advances in …, 2020 - journals.viamedica.pl
Introduction: This document presents the guidelines of the Polish Respiratory Society (PTChP,
Polskie Towarzystwo Chorób Płuc) for diagnosis and treatment of idiopathic pulmonary …

N-acetylcysteine inhibits IL-8 and MMP-9 release and ICAM-1 expression by bronchoalveolar cells from interstitial lung disease patients

…, E Jankowska-Steifer, M Sobiecka… - Pharmacological …, 2010 - Springer
N-acetylcysteine (NAC), owing to its antioxidant, mucolytic and anti-inflammatory properties,
is used in the treatment of various pulmonary disorders. However, the direct effects of NAC …

[HTML][HTML] The presence of T Allele (rs35705950) of the MUC5B gene predicts lower baseline forced vital capacity and its subsequent decline in patients with …

…, K Błasińska, M Falis, K Błaszczyk, M Sobiecka… - International Journal of …, 2023 - mdpi.com
Hypersensitivity pneumonitis (HP) is an exposure-related interstitial lung disease with two
phenotypes—fibrotic and non-fibrotic. Genetic predisposition is an important factor in the …

[HTML][HTML] Can a new scoring system improve prediction of pulmonary hypertension in newly recognised interstitial lung diseases?

M Sobiecka, K Lewandowska, J Kober, M Franczuk… - Lung, 2020 - Springer
… They covered a significantly shorter distance during 6MWT (478 vs 583 m), with significantly
lower mean sat 0 (95.8 vs 96.6%) and mean sat 6 (89.1 vs 93.4%) compared to group A. …

[HTML][HTML] Correlation of serum vascular endothelial growth factor-D concentration with clinical presentation and course of lymphangioleiomyomatosis

E Radzikowska, P Jaguś, M Sobiecka… - Respiratory …, 2015 - Elsevier
Background Increased serum vascular endothelial growth factor D (VEGF-D) concentration
has been accepted as a diagnostic marker in lymphangioleiomyomatosis (LAM). The study …

[HTML][HTML] Hetero-Diels-Alder Reactions of In Situ-Generated Azoalkenes with Thioketones; Experimental and Theoretical Studies

G Mlostoń, K Urbaniak, M Sobiecka, H Heimgartner… - Molecules, 2021 - mdpi.com
The hetero-Diels-Alder reactions of in situ-generated azoalkenes with thioketones were shown
to offer a straightforward method for an efficient and regioselective synthesis of scarcely …

[HTML][HTML] New 6-Minute-Walking Test Parameter—Distance/Desaturation Index (DDI) Correctly Diagnoses Short-Term Response to Immunomodulatory Therapy in …

…, M Sobiecka, PW Boros, M Dybowska… - Diagnostics, 2023 - mdpi.com
… 6MWT was performed as a routine procedure in every patient who was able to walk on a
flat 30 m long corridor, with baseline and sixth-minute room air oxygen saturation, according to …

[HTML][HTML] Factors Predictive for Immunomodulatory Therapy Response and Survival in Patients with Hypersensitivity Pneumonitis—Retrospective Cohort Analysis

…, M Sobiecka, P Radwan-Rohrenschef, M Dybowska… - Diagnostics, 2022 - mdpi.com
Hypersensitivity pneumonitis (HP) is one of the interstitial lung diseases with clearly established
diagnostic criteria. Nevertheless, pharmacologic treatment recommendations are still …